Early infectious risk in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis according to remission-induction therapy.
M GérardHubert de BoyssonR MorelloN Martin-SilvaA-C LerouxAnaël DumontG MaignéJ BoutemyK KhoyDelphine MariotteThierry LobbedezAchille AoubaSamuel DeshayesPublished in: Scandinavian journal of rheumatology (2022)
Within 6 months of RIT, rates of survival without severe infection were similar in newly diagnosed ANCA-positive AAV patients treated with RTX or CYC, but survival rates without infections of any severity appeared to be lower with RTX treatment.